KRYS - Krystal Biotech - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KRYS is currently covered by 8 analysts with an average price target of $237.51. This is a potential upside of $48.43 (25.61%) from yesterday's end of day stock price of $189.08.

Krystal Biotech's activity chart (see below) currently has 112 price targets and 96 ratings on display. The stock rating distribution of KRYS is 88.89% BUY and 11.11% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 79.86% with an average time for these price targets to be met of 281.08 days.

Highest price target for KRYS is $255, Lowest price target is $166, average price target is $209.

Most recent stock forecast was given by ALEC STRANAHAN from BAML on 16-Oct-2025. First documented stock forecast 17-Oct-2017.

Currently out of the existing stock ratings of KRYS, 24 are a BUY (88.89%), 3 are a HOLD (11.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$255

$68.87 (37.00%)

$192

15 days ago
(16-Oct-2025)

3/4 (75%)

$64.77 (34.05%)

284

Buy

$240

$53.87 (28.94%)

$240

1 months 17 days ago
(14-Sep-2025)

24/36 (66.67%)

$84.29 (54.13%)

210

Buy

$216

$29.87 (16.05%)

$219

2 months 10 days ago
(21-Aug-2025)

7/14 (50%)

$65.51 (43.53%)

409

Hold

$166

$-20.13 (-10.82%)

$215

2 months 27 days ago
(04-Aug-2025)

2/5 (40%)

$28.65 (20.86%)

94

Buy

$202

$15.87 (8.53%)

$130

5 months 25 days ago
(06-May-2025)

4/5 (80%)

$65.2 (47.66%)

352

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KRYS (Krystal Biotech) average time for price targets to be met?

On average it took 281.08 days on average for the stock forecasts to be realized with a an average price target met ratio 79.86

Which analyst has the current highest performing score on KRYS (Krystal Biotech) with a proven track record?

JOSH SCHIMMER

Which analyst has the most public recommendations on KRYS (Krystal Biotech)?

Josh Schimmer works at CANTOR FITZGERALD and has 3 price targets and 4 ratings on KRYS

Which analyst is the currently most bullish on KRYS (Krystal Biotech)?

Alec Stranahan with highest potential upside - $68.87

Which analyst is the currently most reserved on KRYS (Krystal Biotech)?

Wangzhi Li with lowest potential downside - -$136.13

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?